Vitamin D Receptor (VDR) Human siRNA Oligo Duplex (Locus ID 7421)
CAT#: SR322180
VDR (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Need single siRNA in bulk? 
                            Get a free quote
                        
SR322180 is the updated version of SR305070.
                
                
            CNY 4090.00
货期*
                        4周
                    规格
                        | Cited in 2 publications. | 
Product images
                    
                
                         推荐一起购买 (3)
                    
                    
                Specifications
| Product Data | |
| Purity | HPLC purified | 
| Quality Control | Tested by ESI-MS | 
| Sequences | Available with shipment | 
| Stability | One year from date of shipment when stored at -20°C. | 
| # of transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). | 
| Note | Single siRNA duplex (10nmol) can be ordered. | 
| Reference Data | |
| RefSeq | NM_000376, NM_001017535, NM_001017536, NM_001364085 | 
| Synonyms | NR1I1; PPP1R163 | 
| Components | VDR (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 7421)Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmolIncluded - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml | 
| Summary | This gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily of ligand-inducible transcription factors. This receptor also functions as a receptor for the secondary bile acid, lithocholic acid. Downstream targets of vitamin D3 receptor are principally involved in mineral metabolism, though this receptor regulates a variety of other metabolic pathways, such as those involved in immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018] | 
| Performance Guranteed | OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency. For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required).  | 
        
Citations (2)
| The use of this RNAi has been cited in the following citations: | 
|---|
| 
                                                Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor
                                                ,Li, Y;Cook, KL;Yu, W;Jin, L;Bouker, KB;Clarke, R;Hilakivi-Clarke, L;,
                                                Nutrients
                                                ,PubMed ID 34069442
                                                [VDR]
                                                 | 
                                        
| 
                                                Intranasal administration of vitamin D attenuates blood–brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44/P-gp glycosylation signaling after subarachnoid hemorrhage in rats
                                                ,null,
                                                Journal of Cerebral Blood Flow  &  Metabolism
                                                ,PubMed ID 27671249
                                                [VDR]
                                                 | 
                                        
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        